Skip to main content

Table 4 Illustrates the variation in methods used to record performance status, co-morbidity and quality of life

From: Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

 

Performance status

Co-morbidity

Quality of Life (QOL)

ECOG/WHO

Karnofsky

Charlson

ACE 27

Specific

Other

EORTC

FACT-G

SF-36

FACIT

Other

Albania

Yes

Yes

  

Yes

     

None

Austria

Yes

    

Research

    

Research

Belgium

Yes

 

Yes

   

Yes*

    

B & H

Yes

 

Yes

   

Yes

    

Bulgaria

Yes

Yes**

  

Yes

 

Yes*

    

Croatia

Yes

Yes

  

Yes

     

None

Czech Rep

Yes

    

None

Yes

Yes

   

Denmark

Yes

 

Yes

 

Yes

 

Yes

   

EORTC LC13

Eng & Wales

Yes

 

Yes

Yes

No*

 

Yes*

 

Yes*

  

Estonia

Yes*

Yes*

   

None

    

None

Finland

Yes

Yes**

  

Yes

     

Research

France

Yes

 

Yes

   

Yes

    

Germany

Yes

Yes

Yes*

   

Yes*

    

Greece

Yes

Yes

Yes*

Yes*

Yes*

 

Yes*

Yes*

Yes*

Yes*

 

Hungary

Yes

Yes

   

None

     

Iceland

Yes

   

Yes

 

Yes*

    

Rep. Ireland

Yes

    

None

Yes*

 

Yes*

  

Italy

Yes

Yes

  

Yes

 

Yes

    

Lithuania

Yes

    

None

    

None

Luxembourg

Yes

 

Yes

       

None

Malta

Yes

Yes

  

Yes

 

Yes

    

Moldova

 

Yes

   

None

  

Yes

  

Netherlands

Yes

 

Yes

   

Yes*

    

Norway

Yes

 

Yes*

   

Yes

Yes**

Yes**

Yes**

 

Poland

Yes

   

Yes

 

Yes

    

Portugal

Yes

Yes**

Yes

   

Yes*

    

Romania

Yes

    

None

    

None

Scotland

Yes

    

SLCFCSS

Yes*

    

Rep. Serbia

Yes

   

Yes**

 

Yes**

    

Slovakia

Yes

Yes

  

Yes

 

Yes*

    

Slovenia

Yes

   

Yes

     

None

Spain

Yes

   

Yes

     

None

Sweden

Yes

    

No**

Yes

    

Switzerland

 

Yes

Yes

       

Variation

Turkey

Yes

Yes

   

None

Yes*

Yes*

   
  1. Legend: Charlson = Charlson Index [9]
  2. ACE 27 Adult Co-morbidity Evaluation score [10], SLCFCSS Scottish Lung Cancer Forum Co-morbidity Scoring System [45], Specific specific co-morbid diseases are recorded, EORTC QLQ-C30 European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire [46], FACT-G Functional Assessment Cancer Therapy-General [47], SF-36 Short Form-36 [48], FACIT Functional Assessment Chronic Illness Therapy [49]
  3. Yes* = research/clinical trials only
  4. Yes** = infrequently
  5. No* = no longer used
  6. No** = Co-morbidity recorded only if it prevented planned treatment